Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NB235727

Novus Biologicals MYO3A Recombinant Protein Antigen
SDP

Catalog No. NB235727 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB235727 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB235727 Supplier Novus Biologicals Supplier No. NBP317742PEP
Only null left
Add to Cart
Add to Cart

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1M Urea, pH 7.4.
Gene ID (Entrez) 53904
Molecular Weight (g/mol) M.W. (Theoretical): 27 kDa
Quantity 0.1 mL
Storage Requirements Store at -20C. Avoid freeze-thaw cycles.
Gene Alias deafness, autosomal recessive 30, DFNB30, EC 2.7.11, EC 2.7.11.1, myosin IIIA, myosin-IIIa
Gene Symbol MYO3A
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP3-17742It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL.For current lot information, including availability, please contact our technical support team click nb-technical@bio-techne.com For further blocking peptide related information and a protocol, click here .
Research Category Protein Kinase, Vision
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein MYO3A
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.